Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Cardiovascular Drugs and Therapy|June 20, 2025
Direct Oral Anticoagulants in Valvular Diseases and Prosthetic Valves: Why Not?Konstantinos Lampropoulos, Michail Penteris, Grigorios Gerotziafas
Scientific Reports|April 4, 2026
Colorectal cancer cells respond differentially to autophagy induced by tyrosine kinase inhibitorsLila Louadj, Grigorios Gerotziafas, Michèle Sabbah, et al.
Annales De Biologie Clinique|November 16, 2013
[The usefulness of platelet function evaluation in clinical practice]Ismail Elalamy, Vasiliki Gkalea, Grigorios Gerotziafas, et al.
Studies in Health Technology and Informatics|August 24, 2019
Development and Assessment of RecosDoc-MTeV to Improve the Quality of Direct Oral Anticoagulant Prescription for Venous Thromboembolic DiseaseBrigitte Séroussi, Houda Ouarrirh, Ismaël Elalamy, et al.
The American Journal of Case Reports|May 29, 2019
Missed Heparin-Induced Thrombocytopenia (HIT) Diagnosis in a Patient with Acute Stent ThrombosisVassilis Voudris, Panagiota Georgiadou, Panagiotis Kalogris, et al.
BMC Pulmonary Medicine|January 30, 2021
Severe COVID-19 with acute respiratory distress syndrome (ARDS) in a sickle cell disease adult patient: case reportMarion Teulier, Alexandre Elabbadi, Grigorios Gerotziafas, et al.
Autoimmunity Reviews|February 3, 2022
Drug-induced antiphospholipid syndrome: Analysis of the WHO international databaseChristel Gérardin, Kevin Bihan, Joe Elie Salem, et al.
Medicina (Kaunas, Lithuania)|May 4, 2026
Patient Satisfaction with Anticoagulation for Venous Thromboembolic Disease: A Systematic Review of Oral and Parenteral RegimentsEleftheria Elmina Lefkou, Anastasia Fragkaki, Maria Mirsini Miliori, et al.
ERJ Open Research|December 16, 2021
Endothelial dysfunction and hypercoagulability in severe sickle-cell acute chest syndromeEtienne-Marie Jutant, Guillaume Voiriot, Vincent Labbé, et al.
Pageof 3